Literature DB >> 33332590

Validation of the caregiver Pediatric Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events measure.

Bryce B Reeve1, Molly McFatrich1, Li Lin1, Nicole R Lucas1, Jennifer W Mack2, Shana S Jacobs3, Janice S Withycombe4, Justin N Baker5, David R Freyer6, Pamela S Hinds3,7.   

Abstract

BACKGROUND: Despite improvements in survival rates, cancer treatments have significant side effects that affect the quality of life of children and their families. When an ill child cannot self-report symptoms (eg, he or she is too ill), caregiver (parent) reporting becomes critical. This study evaluates the validity and reliability of the caregiver-reported Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (Ped-PRO-CTCAE [Caregiver]) measure.
METHODS: A diverse sample of caregivers with children receiving treatment at 9 oncology centers completed the Ped-PRO-CTCAE [Caregiver] measure, the Patient-Reported Outcomes Measurement Information System® (PROMIS® ) Parent Proxy measures, the Lansky Play-Performance Scale (PPS), medication use questions, and Global Impressions of Change (GIC). Construct validity (including convergent, discriminant, and known groups validity and responsiveness over time) and reliability (stability) were examined.
RESULTS: A majority of the 473 caregivers were female (85%), non-Hispanic White (61%), and married (75%). Symptoms assessed with the Ped-PRO-CTCAE [Caregiver] and PROMIS Parent Proxy measures were strongly correlated (e.g., r for pain = 0.78; r for fatigue = 0.78; and r for depression = 0.83). Most of the Ped-PRO-CTCAE [Caregiver] item mean scores distinguished among PPS function levels and between children who did take medications for symptom control and children who did not. Changes in Ped-PRO-CTCAE [Caregiver] item mean scores were responsive to GIC over time. Test-retest evaluation found moderate to high agreement (57.8%-93.3%) over time.
CONCLUSIONS: This study found strong evidence for the convergent and discriminant validity, known groups validity, responsiveness, and stability of the Ped-PRO-CTCAE [Caregiver] measure in a large and diverse sample of caregivers. The caregiver perspective provides a valuable and unique insight into the experiences of children and adolescents undergoing cancer treatment. LAY
SUMMARY: Despite advances in cancer treatments, children and adolescents continue to suffer from treatment side effects, including pain, nausea, fatigue, and emotional distress, that can adversely affect quality of life for children and their families. Although it is best for children to report how they are feeling, there are times when a child may be too young or too ill to self-report. This study provides critical evidence for a new type of questionnaire that allows the caregiver or parent to report accurately what the child is experiencing. This measure can be used to improve adverse event reporting and child cancer care.
© 2020 American Cancer Society.

Entities:  

Keywords:  adverse event; cancer; caregiver; pediatric; symptoms

Mesh:

Year:  2020        PMID: 33332590      PMCID: PMC8734933          DOI: 10.1002/cncr.33389

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  30 in total

1.  Development and validation of the pediatric nausea assessment tool for use in children receiving antineoplastic agents.

Authors:  L Lee Dupuis; Anna Taddio; Elizabeth N Kerr; Andrea Kelly; Linda MacKeigan
Journal:  Pharmacotherapy       Date:  2006-09       Impact factor: 4.705

2.  Measuring quality of life in children with asthma.

Authors:  E F Juniper; G H Guyatt; D H Feeny; P J Ferrie; L E Griffith; M Townsend
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

3.  Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

Authors:  Ethan Basch; Bryce B Reeve; Sandra A Mitchell; Steven B Clauser; Lori M Minasian; Amylou C Dueck; Tito R Mendoza; Jennifer Hay; Thomas M Atkinson; Amy P Abernethy; Deborah W Bruner; Charles S Cleeland; Jeff A Sloan; Ram Chilukuri; Paul Baumgartner; Andrea Denicoff; Diane St Germain; Ann M O'Mara; Alice Chen; Joseph Kelaghan; Antonia V Bennett; Laura Sit; Lauren Rogak; Allison Barz; Diane B Paul; Deborah Schrag
Journal:  J Natl Cancer Inst       Date:  2014-09-29       Impact factor: 13.506

4.  A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research.

Authors:  Terry K Koo; Mae Y Li
Journal:  J Chiropr Med       Date:  2016-03-31

5.  Psychometric Evaluation of the PROMIS® Pediatric Psychological and Physical Stress Experiences Measures.

Authors:  Katherine B Bevans; William Gardner; Kathleen A Pajer; Brandon Becker; Adam Carle; Carole A Tucker; Christopher B Forrest
Journal:  J Pediatr Psychol       Date:  2018-07-01

6.  PROMIS® Parent Proxy Report Scales for children ages 5-7 years: an item response theory analysis of differential item functioning across age groups.

Authors:  James W Varni; David Thissen; Brian D Stucky; Yang Liu; Brooke Magnus; Hally Quinn; Debra E Irwin; Esi Morgan DeWitt; Jin-Shei Lai; Dagmar Amtmann; Heather E Gross; Darren A DeWalt
Journal:  Qual Life Res       Date:  2013-06-06       Impact factor: 4.147

7.  Impact of a child's cancer disease on parents' everyday life: a longitudinal study from Sweden.

Authors:  Emma Hovén; Helena Grönqvist; Ulrika Pöder; Louise von Essen; Annika Lindahl Norberg
Journal:  Acta Oncol       Date:  2016-11-11       Impact factor: 4.089

8.  PROMIS® Parent Proxy Report Scales: an item response theory analysis of the parent proxy report item banks.

Authors:  James W Varni; David Thissen; Brian D Stucky; Yang Liu; Hally Gorder; Debra E Irwin; Esi Morgan DeWitt; Jin-Shei Lai; Dagmar Amtmann; Darren A DeWalt
Journal:  Qual Life Res       Date:  2011-10-05       Impact factor: 4.147

9.  The first step to integrating the child's voice in adverse event reporting in oncology trials: a content validation study among pediatric oncology clinicians.

Authors:  Bryce B Reeve; Janice S Withycombe; Justin N Baker; Mary C Hooke; Jessica C Lyons; Catriona Mowbray; Jichuan Wang; David R Freyer; Steven Joffe; Lillian Sung; Deborah Tomlinson; Stuart H Gold; Pamela S Hinds
Journal:  Pediatr Blood Cancer       Date:  2013-01-17       Impact factor: 3.167

10.  Impact of caring for a child with cancer on parents' health-related quality of life.

Authors:  Anne F Klassen; Robert Klaassen; David Dix; Sheila Pritchard; Rochelle Yanofsky; Maureen O'Donnell; Amie Scott; Lillian Sung
Journal:  J Clin Oncol       Date:  2008-11-24       Impact factor: 44.544

View more
  3 in total

1.  Lack of Concordance in Symptomatic Adverse Event Reporting by Children, Clinicians, and Caregivers: Implications for Cancer Clinical Trials.

Authors:  David R Freyer; Li Lin; Jennifer W Mack; Scott H Maurer; Molly McFatrich; Justin N Baker; Shana S Jacobs; Nicole Lucas; Janice S Withycombe; Deborah Tomlinson; Katie Rose Villabroza; Mia K Waldron; Pamela S Hinds; Bryce B Reeve
Journal:  J Clin Oncol       Date:  2022-03-16       Impact factor: 50.717

2.  Can Steps per Day Reflect Symptoms in Children and Adolescents Undergoing Cancer Treatment?

Authors:  Janice S Withycombe; Molly McFatrich; Pamela S Hinds; Antonia Bennett; Li Lin; Scott H Maurer; Nicole R Lucas; Courtney M Mann; Sharon M Castellino; Justin N Baker; Bryce B Reeve
Journal:  Cancer Nurs       Date:  2022-02-05       Impact factor: 2.760

3.  Symptom screening via screen: Real-time electronic tracking of pediatric patient-reported outcomes.

Authors:  Meaghann S Weaver; Lori Wiener
Journal:  Cancer       Date:  2021-05-04       Impact factor: 6.921

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.